Publication | Open Access
CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure
151
Citations
15
References
2020
Year
Monthly repeated dosing of CDR132L is safe and adequate to provide clinically relevant exposure and therapeutic efficacy in a model of chronic post-MI HF. CDR132L thus should be explored as treatment for the broad area of chronic heart failure.
| Year | Citations | |
|---|---|---|
Page 1
Page 1